Australia has fallen short of its first-week COVID vaccination goal, delivering just half of the expected number of doses, according to the first comprehensive official count.
What Is COVAX?
COVID-19 Vaccines Global Access, better known as COVAX, is a global platform to support the development, manufacturing, and distribution of COVID-19 vaccines. It was launched in April 2020 by the World Health Organization (WHO), the European Commission, and France as one of the three pillars of the Access to COVID-19 Tool Accelerator.
A crucial aspect of the initiative is the COVAX Facility, which is run by public-private global health partnership known as Gavi, the Vaccine Alliance. The COVAX Facility is a procurement mechanism that purchases vaccines from a portfolio of producers on behalf of countries that are COVAX members. The facility has been working with manufacturers to ensure that they had the capacity to produce large quantities of doses once vaccines were approved. Now, the facility is purchasing and distributing vaccines to its member countries.
America first, world second: Biden s effort for global vaccines is thwarted by U.S. policy Alexander Smith
LONDON It seemed like a windfall in the campaign to vaccinate the world.
President Joe Biden last week announced $4 billion for a humanitarian program called COVAX short for Covid-19 Vaccines Global Access plan which aims to fairly distribute vaccines between rich countries and the developing world.
But in more than a dozen interviews, current and former officials involved with COVAX and experts with detailed knowledge of the plan suggest Biden s mountains of cash and rhetorical support will not address the real reasons behind the dire state of global vaccine inequality.